Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Jul 11, 2014 (12 years ago)

Potassium Chloride Injection

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: particulate matter identified as fibers and/or plastics

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Potassium Chloride Injection, 20 mEq per 50 mL, 50 mL Sterile Single Dose Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-0703-41, Product Code 2B0822.

Affected NDC 0338-0703-41

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Potassium Chloride
NDC 00338-0703
29.8 g/1000mL Injection, Solution
Intravenous
Baxter Healthcare Corporation Rx
Recalling firm
Baxter Healthcare Corp.
NDC code
0338-0703-41
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1593-2014 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Baxter Healthcare Corp.

All 2014 recalls
Class I · High risk

Dextrose Injection

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Ongoing Particulate / foreign matter Baxter Healthcare Corporation NDC 00338-0719-06 D-0850-2026
Class II · Moderate risk

Daptomycin

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 0338-0718-12 D-0821-2026

Other particulate / foreign matter recalls from 2014

All particulate / foreign matter recalls
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-0381-2015
Class I · High risk

0.9% Sodium Chloride Injection USP

Presence of Particulate Matter: Confirmed customer complaints received for the presence of blue plastic, identified as fragments of the frangible from the vial adapter.

Terminated Particulate / foreign matter Baxter Healthcare Corp NDC 0338-0553-18 D-481-2015